Cancer Immunology, Immunotherapy Issues Research Articles in September 2022 Edition
August 13, 2022
August 13, 2022
BASEL, Switzerland, Aug. 13 -- Cancer Immunology, Immunotherapy, a peer-reviewed journal that says it advances in the field of tumor immunology, published research articles on the following topics in its September 2022 edition:
Review Articles:
* Interleukin-12 as an in situ cancer vaccine component: a review
* PD1/PD-L1 immune checkpoint as a potential target for preventing brain tumor progression
* Adoptive cell therapies in thoracic maligna . . .
Review Articles:
* Interleukin-12 as an in situ cancer vaccine component: a review
* PD1/PD-L1 immune checkpoint as a potential target for preventing brain tumor progression
* Adoptive cell therapies in thoracic maligna . . .